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A study of the prevalence of African horse sickness in horses was conducted, using records 
from two private equine practices in Harare for the period 1998–2004. Results indicated a 
higher prevalence of the disease in horses in Zimbabwe in the late rainy season (March – May). 
Age of the horse was found to be a significant risk factor, with foals or yearlings appearing 
to be 1.80 times more likely to contract the disease compared with horses older than two 
years. The case fatality rate in foals or yearlings was also higher than in older age groups, but 
this difference was not significant. The vaccination status was an important risk factor, with 
vaccinated horses 0.12 times less likely to die from the disease compared with unvaccinated 
horses. Young, unvaccinated horses therefore seem to be the most susceptible to the disease 
and  have  greater  chances  of  fatality.  This  study  highlights  the  importance  of  adequately 
protecting  horses  against  African  horse  sickness  by  providing  immunisation  through 
vaccination and discusses the need to review current vaccination strategies being practiced in 
Zimbabwe. 
Introduction
African horse sickness (AHS) is an infectious and non-contagious disease, affecting all species 
of Equidae, caused by a double-stranded RNA orbivirus (Calisher & Mertens 1998). AHS was 
first recognised in southern Africa, with the first major outbreak recorded in 1719, when more 
than 1700 animals died (Theiler 1921 in Mellor & Hamblin 2004). Although endemic in Equidae 
in sub-Saharan Africa, outbreaks have also been recorded in north Africa, the middle and near 
east and southern Europe (MacLachlan & Guthrie 2010). Both AHS and bluetongue viruses are 
transmitted by the biting midges Culicoides. Culicoides imicola is the field vector of AHS virus 
although Culicoides bolitinos has been shown to play an important role in the transmission of AHS 
virus in the cooler upper highlands of South Africa (Meiswinkel & Paweska 2003). The highest 
incidence of the disease usually occurs in the late summer and early autumn in years when the 
climatic conditions favour an abundance of Culicoides midges (Coetzer & Guthrie 2004). 
The distribution of AHS virus is governed by a number of factors, including the efficiency of 
control  measures,  the  presence  of  long-term  vertebrate  reservoirs  and  the  occurrence  of  the 
Culicoides vectors (Mellor & Hamblin 2004). It was shown by Wellby et al. (1996) and Mellor and 
Hamblin (2004) that the virogenesis and infection rates of the Culicoides vectors were directly 
proportional to an increase in temperature, but that the survival rates of Culicoides were inversely 
related to temperature. This suggests that transmission should be possible only at certain times of 
the year, giving the disease the same seasonality as the vector species. Previous studies conducted 
in Zimbabwe have shown the disease is usually diagnosed in late summer and early autumn, with 
most cases occurring towards the end of the rainy season (March – May) (Blackburn & Swanepoel 
1988a). In contrast, Henning (1956) found the disease occurred slightly earlier in South Africa, 
starting in February and declining sharply with the first frosts in May.
The relationship between the fatality rate in horses due to AHS compared with the age of the 
affected horse and the immunity status induced by vaccination was studied in Zimbabwe by 
Blackburn and Swanepoel (1988a). The authors reported 207 cases of clinically diagnosed AHS, 
with 107 deaths, between 1975 and 1980. Furthermore, 56 of these cases, with 50 deaths, were 
recorded in foals. Erasmus (1978) claimed, however, that the age, sex and body condition of the 
host animal have no influence on the susceptibility to AHS in naïve horses. 
AHS cases have been recorded in horses that were vaccinated, suggesting that vaccination does 
not provide adequate protection (Blackburn & Swanepoel 1988a). However, these findings were 
reported when the vaccine used in Zimbabwe contained only AHS virus serotypes one to six, 
unlike the freeze-dried, polyvalent, modified live, attenuated AHS virus vaccine (Onderstepoort 
Biological  Products®)  used  today.  The  current  vaccine  contains  serotypes  one  to  four  and 
serotypes six to eight. Experimental studies have shown that antibody decline in foals with 
maternally derived immunity occurs between two and four months after birth (Blackburn & 
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Swanepoel  1988b).  More  recently,  Crafford  et  al.  (2013) 
reported  that  maternal  antibodies  to  AHS  virus  acquired 
passively by foals born to vaccinated mares varied markedly, 
with  further  variation  noted  in  the  duration  of  passive 
immunity  to  individual  AHS  virus  serotypes.  This  raises 
concern over the general belief amongst horse owners and 
equine veterinarians in Zimbabwe that foals with maternally 
derived immunity should only be vaccinated when between 
six and nine months of age.
Reliable data on AHS in horses are available readily from 
private  practitioners,  although,  since  1998,  reporting  of 
the occurrence of this notifiable disease by veterinarians to 
government veterinary officers has been erratic (O. Kakono 
pers.  comm.,  09  November  2006).  This  has  resulted  in  a 
gap in the knowledge about the disease status in the horse 
population across the country. 
The objectives of this study were to determine the practice 
prevalence of AHS in the Harare region and the distribution 
of  AHS  cases  by  year,  season,  age,  sex,  and  vaccination 
status. The effect of age and vaccination status on case fatality 
was also investigated.
Materials and methods 
Selection of veterinary surgeries, data collection 
and analysis
A convenience sample of two private veterinary surgeries 
in  Harare  was  selected,  based  on  reliable  record  keeping 
and a large equine caseload covering a wide practice area. 
Records of AHS cases available at the two private veterinary 
surgeries, for the period 1998–2004, were used for this study. 
The population of horses at risk was 16 987, as determined 
from  the  annual  horse  census  of  the  Central  Veterinary 
Laboratories of Zimbabwe and from data provided by the 
Horse  Society  of  Zimbabwe,  the  Mashonaland  Turf  Club, 
the  Thoroughbred  Association  of  Zimbabwe,  the  Polo 
Association  of  Zimbabwe  and  the  Polo  X  Association  of 
Zimbabwe. Horses included in this population were from 
the districts of Marondera, Harare and Goromonzi, which 
represented the practice area of the two veterinary practices.
Diagnosis  of  AHS  was  based  on  clinical  signs  and  post-
mortem  lesions  recognised  by  the  veterinarian  or  during 
laboratory  diagnosis.  The  laboratory  diagnosis  was  based 
on the antigen-capture enzyme-linked immunosorbent assay 
(ELISA) as described previously by Hamblin et al. (1991). No 
repeat cases of AHS in individual horses were recorded in 
any year.
A total of 8529 horses, representing 50.2% of the 16 987 horses 
in the study area, were attended to by the two private practices 
during the study period. Of the 8529 horses attended to, 980 
(11.5%) were foals or yearlings (< two years of age).
Data  were  extracted  from  each  case  record,  including  the 
date of diagnosis, age, sex, vaccination status and disease 
outcome  of  each  affected  horse.  The  diagnosis  date  was 
used to determine the annual and monthly cases and the 
seasonality of the disease. The following seasonal categories 
were generated: early rainy season (December – February), 
late rainy season (March – May), cold dry season (June – 
August), and the warm dry season (September – November). 
Age of the case horses was categorised into three groups: 
foals or yearlings (< two years of age), subadults (two to five 
years of age) and adults (> five years of age).
The  annual  practice  prevalence  and  annual  case  fatality 
rates for AHS were calculated for the years 1998–2004. The 
practice prevalence and case fatality rates for AHS, stratified 
by  season,  year  and  age,  were  calculated  over  the  whole 
study period. The effect of age on the odds of contracting 
AHS was evaluated by calculating the odds ratio (OR) and 
95% confidence intervals (CI). The OR was also calculated for 
the effect of age and the effect of vaccination status on the 
odds of fatality due to AHS. 
Results
The  practice  prevalence  of  AHS  during  the  study  period 
was 1.96% (167/8529). The average annual number of AHS 
cases recorded was 24, with the highest practice prevalence 
recorded in 2003 and the lowest in 1998 (Table 1). 
Page 2 of 5
TABLE 1: The annual practice prevalence of African horse sickness in horses recorded by two Harare equine practices for the period 1998–2004.
Variable Level AHS cases Number of horses 
seen by practices
AHS prevalence 
(%)
95% CI†  AHS fatalities AHS case 
fatality rate
Year 1998 9 1580 0.57 0.30–1.11 6 66.7
1999 34 1381 2.46 1.77–3.42 21 61.8
2000 47 1330 3.53 2.66–4.66 15 31.9
2001 19 1230 1.54 0.99–2.39 7 36.8
2002 10 1036 0.97 0.53–1.77 3 30.0
2003 36 980 3.67 2.66–5.04 12 33.3
2004 12 992 1.21 0.69–2.10 3 25.0
Season Early rainy
(December – February)
15 8529 0.18 0.11–0.30 - -
Late rainy
(March – May)
115 8529 1.35 1.13–1.62 - -
Cold dry
(June – August)
31 8529 0.36 0.25–0.51 - -
Warm dry
(September – November)
6 8529 0.07 0.03–0.15 - -
Age Foals or yearlings 31 980 3.16 2.23–4.45 16 51.6
> two years of age 136 7549 1.80 1.52–2.13 25 36.8
AHS, African horse sickness; CI, confidence interval.
†, Lowry, R., 2013, ‘The confidence interval of a proportion’, in VassarStats: Website for Statistical Computation, viewed 11 February 2013, from http://www.vassarstats.net/prop1.htmlOriginal Research
doi:10.4102/ojvr.v80i1.578  http://www.ojvr.org
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Across  all  years,  the  highest  numbers  of  AHS  cases  were 
recorded  from  March  (16.2%;  27/167)  to  June  (18.0%; 
30/167), with peak numbers reached in April (21.0%; 35/167) 
and May (31.7%; 53/167). From July onwards, the number 
of cases decreased dramatically, with no cases recorded in 
August and November. The late rainy season recorded the 
highest number of cases (68.9%; 115/167), whilst the lowest 
number of cases (3.6%; 6/167) was recorded in the warm dry 
season (Table 1). 
Male horses accounted for 48.5% (81/167) of the AHS cases 
recorded, whilst female horses accounted for 36.5% of the 
cases  (61/167).  No  sex  identification  was  recorded  in  the 
medical records of 25 horses. The highest numbers of AHS 
cases  were  recorded  in  adult  horses  and  subadults,  with 
these groups accounting for 40.7% (68/167) of the total AHS 
cases recorded. The lowest number of cases (18.6%; 31/167) 
was recorded in foals or yearlings. 
Foals  or  yearlings  recorded  a  higher  prevalence  of  AHS 
compared with horses older than two years (Table 1). The 
odds of AHS developing were 1.8 times greater in foals or 
yearlings  (95%  CI:  1.3–2.9)  compared  with  horses  older 
than two years. The majority of the horses with AHS had 
previously been vaccinated against AHS (85%; 142/167). 
The average annual number of fatalities due to AHS was 
9.6, with the highest case fatality rates recorded in 1998 and 
1999  and  the  lowest  in  2004  (Table  1).  Foals  or  yearlings 
recorded  the  highest  overall  case  fatality  rate,  followed 
by  adults  and  subadults.  The  odds  of  foals  or  yearlings 
dying from AHS were 1.8 times greater (95% CI: 0.90–4.30) 
compared with horses older than two years, although the 
odds were not significantly different. Unvaccinated horses 
recorded a higher overall case fatality rate compared with 
vaccinated horses (Table 1). Higher case fatality rates were 
recorded for unvaccinated foals or yearlings, subadults and 
adult  horses  compared  with  their  respective  vaccinated 
age  categories  (Table  2).  Unvaccinated  subadults  had  the 
highest case fatality rates, followed by unvaccinated adults 
and  unvaccinated  foals  (Table  2).  The  odds  of  vaccinated 
horses  dying  from  AHS  were  0.12  times  less  likely 
(95% CI: 0.044–0.350) compared with unvaccinated horses. 
Discussion 
The prevalence of AHS in Zimbabwe recorded during the 
present study was lower than in previous reports (Blackburn 
1982;  Blackburn  &  Swanepoel  1988a;  Musuka  1999). 
Blackburn and Swanepoel (1988a) recorded 207 cases of AHS 
from 1654 horses studied in Zimbabwe in 1980, representing 
a 12% prevalence compared to a 1.96% prevalence found in 
this  study.  This  could  possibly  be  attributed  to  improved 
vaccination and control measures practiced in the country 
during this current study period. It is also important to note 
that the prevalence of AHS recorded in this study may be 
an underestimation of true values, as results are based on 
a convenience sample taken from two veterinary surgeries 
only. Not all cases of AHS in the horse population, within 
the catchment area under study, may have been presented to 
these two surgeries.
The prevalence of AHS was higher in years that experienced 
early rains followed by a dry spell (rainfall data supplied 
by the Dept. of Meteorological Services, Harare) and there 
was a definite seasonal distribution, with most cases being 
diagnosed between late summer and autumn (February – 
June).  These  findings  concurred  with  observations  from 
earlier studies in Zimbabwe (Blackburn & Swanepoel 1988a). 
The  seasonality  of  the  disease  is  also  affected  by  vector 
patterns. The infection rates of the vector, Culicoides, and the 
rate of virogenesis increase with increasing environmental 
temperature  although  the  rate  of  adult  fly  mortality  may 
also increase (Mellor & Hamblin 2004; Wellby et al. 1996). 
Culicoides imicola, however, breed only in wet or damp areas, 
which may explain why AHS cases are low in the warm, dry 
months despite high environmental temperatures favouring 
increased rates of virogenesis and infection (Baylis, Mellor & 
Meiswinkel 1999). 
It has been proposed that a strong link exsits between major 
outbreaks of AHS in southern Africa and the warm phase of 
the El Niño–Southern Oscillation (ENSO) (Baylis et al. 1999). 
It has been suggested that this link is due to the combination 
of heavy rain and drought that the ENSO brings to southern 
Africa, creating breeding conditions that allow the Culicoides 
vector  to  increase  more  than  200-fold  (Baylis  et  al.  1999; 
Meiswinkel, Nevill & Venter 1994; Mellor & Hamblin 2004). 
The  results  of  the  present  study  support  this  suggestion, 
as the highest practice prevalence (3.67%) was recorded in 
2003 when a large ENSO was reported. The lowest practice 
prevalence (0.57%) was recorded in 1998 when the ENSO 
was  weak  and  a  moderate  La  Niña–Southern  Oscillation 
was reported (National Institute of Water and Atmospheric 
Research  2013).  Furthermore,  it  has  been  predicted  by 
TABLE 2: Case fatality rates for African horse sickness in vaccinated and unvaccinated horses according to age group.
Age group Vaccination status Total number of cases Total fatalities Case fatality rate (%) 95% CI†
Foals or yearlings Unvaccinated 3 2 67 20.8–93.9
Vaccinated 28 14 50 32.6–67.4
Subadults Unvaccinated 8 7 88 52.9–97.8
Vaccinated 60 18 30 19.9–42.5
Adults Unvaccinated 14 11 79 52.4–92.4
Vaccinated 54 15 28 17.6–40.9
CI, confidence interval.
†, Lowry, R., 2013, ‘The confidence interval of a proportion’, in VassarStats: Website for Statistical Computation, viewed 11 February 2013, from  http://www.vassarstats.net/prop1.html    Original Research
doi:10.4102/ojvr.v80i1.578  http://www.ojvr.org
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Wittmann  and  Baylis  (2000)  that  the  distribution  of 
C.  imicola  will  become  more  widespread  with  increasing 
global temperatures, bringing the AHS virus into the range 
of other Culicoides species that are known to be competent 
vectors of this disease. 
The results of the present study showed that the age of the 
horse  was  associated  with  the  occurrence  of  AHS  in  this 
population, with foals or yearlings having greater odds of 
developing  the  disease  than  older  horses.  These  findings 
concur  with  earlier  observations  in  Zimbabwe  (Blackburn 
& Swanepoel 1988a), although Erasmus (1978) claimed that 
age  had  no  influence  on  susceptibility  to  the  disease.  As 
supported by the findings of this study, age susceptibility 
and survival may be linked to the immune status of a horse 
due to vaccination. The response to vaccination is therefore 
important,  as  the  immune  status  of  the  horse  modifies 
the form of the disease and thus the associated mortality. 
However,  despite  high  levels  of  horse  vaccination  in 
Zimbabwe, a high prevalence of AHS was recorded. A high 
prevalence of AHS in vaccinated horses in the country was 
also  reported  previously  (Blackburn  &  Swanepoel  1988a). 
The  polyvalent  vaccine  in  use  at  the  time  of  that  study 
(1980)  included  attenuated  strains  of  serotypes  one  to  six 
only (Blackburn & Swanepoel 1988a). In the present study, 
however, cases still occurred in vaccinated horses, although 
the  polyvalent  vaccine  used  now  also  includes  serotypes 
seven and eight. Furthermore, Weyer et al. (2013) showed 
that horses immunised against AHS virus can be infected 
both clinically and subclinically with AHS virus following 
natural infection in field conditions, with 16% of immunised 
horses being infected over a two-year period.
The higher case fatality rates recorded in foals or yearlings 
may be due to incomplete protection against the AHS virus 
after  the  initial  vaccination,  which  has  been  attributed  to 
interference between the virus serotypes (Coetzer & Guthrie 
2004). Some strains of vaccine may also be immunogenically 
weak and several courses of vaccination may be required to 
achieve full immunity to the AHS virus, thus making foals 
or yearlings that have not yet received multiple vaccinations 
more  susceptible  (Laegreid  1996).  Experimental  studies 
conducted  by  Blackburn  and  Swanepoel  (1988a)  showed 
that multiple vaccinations with attenuated strains of AHS 
serotypes one to six led to a broader response to various 
serotypes and to a higher individual serotype titre. However, 
it has been highlighted that although protective responses 
to  all  the  virus  serotypes  in  the  polyvalent  vaccine  may 
be  achieved  only  after  repeated  immunisation,  excessive 
administration of vaccine over many years appears to lead to a 
state of immunological unresponsiveness or hypersensitivity 
(Erasmus  1978).  This  could  explain  why  there  is  often  an 
increase in cases of AHS in older horses. Improper storage 
of the vaccine or incorrect administration of the vaccine may 
also contribute to vaccine failure.
Crafford et al. (2013) reported a mean half-life of only 20.5 days 
for passively acquired maternal neutralising antibody to AHS 
virus recorded in six foals in an endemic area in the Western 
Cape province of South Africa. Blackburn and Swanepoel 
(1988b) showed that passively acquired antibodies in foals 
against individual AHS serotypes declined to undetectable 
levels between two and four months of age. Furthermore, 
the vaccination of foals between three and four months of 
age resulted in a weak antibody response, which did not 
adversely affect pre-existing low levels of maternal antibody 
(Blackburn & Swanepoel 1988b). Thus, foals from vaccinated 
dams may succumb to AHS as early as at three months of 
age and immunisation at an earlier age could therefore help 
to control foal susceptibility to and mortality from AHS. The 
effectiveness  of  the  current  vaccination  strategies  against 
AHS  used  in  Zimbabwe  may,  therefore,  require  revision. 
The vaccination of younger foals with maternally derived 
antibody against some serotypes of AHS could be considered 
instead of the current practice of vaccinating foals only older 
than six months in Zimbabwe.
The sex of the horse was not adequately investigated as a 
possible risk factor as the sex composition of the original 
population was unknown, thus necessitating the need for 
further studies in this area.
Conclusion
The age of the horse was found to be significantly associated 
with AHS, with foals or yearlings more likely to contract 
the disease compared with horses older than two years. The 
AHS case fatality rate in foals or yearlings was also found 
to  be  higher  than  in  older  age  groups.  Furthermore,  the 
vaccination status was found to be an important risk factor, 
with vaccinated horses less likely to die from AHS compared 
with unvaccinated horses. 
It appears, therefore, that young, unvaccinated horses seem 
to  be  the  most  susceptible  to  AHS  and  that  they  suffer 
greater  chances  of  fatality.  This  reinforces  the  importance 
of  adequately  protecting  horses  against  AHS  through 
vaccination,  highlighting  the  need  to  review  current 
vaccination strategies being practised in Zimbabwe.
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